International trade · 18/04/2012Updated: 10/17/2026 · 1 min read
Novartis Consumer Health, Inc. Receives Temporary/Interim Manufacturing Authority for Pharmaceutical Product Manufacturing in Foreign-Trade Zone 59
Summary
Novartis Consumer Health, Inc. has been granted a temporary/interim manufacturing authority for pharmaceutical product manufacturing in Foreign-Trade Zone 59, as announced by the relevant authorities.
Original source language: Federal Register — Department of CommerceOpen original release →